Randomized controlled study on preoperative chemoradiotherapy followed by surgery versus surgery alone for esophageal squamous cell cancer in a single institution

被引:118
作者
Natsugoe, S. [1 ]
Okumura, H. [1 ]
Matsumoto, M. [1 ]
Uchikado, Y. [1 ]
Setoyama, T. [1 ]
Yokomakura, N. [1 ]
Ishigami, S. [1 ]
Owaki, T. [1 ]
Aikou, T. [1 ]
机构
[1] Kagoshima Univ, Sch Med, Dept Surg Oncol & Digest Surg, Kagoshima 890, Japan
关键词
chemoradiation therapy; esophageal cancer; randomized controlled study;
D O I
10.1111/j.1442-2050.2006.00615.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The purpose of the present study was to compare the clinical results between preoperative chemoradiotherapy followed by surgery (CRT group) and surgery alone (Surgery group) by a randomized controlled study. Twenty-two patients were assigned to the CRT group and 23 to the Surgery group. A total radiation dose of 40 Gy was applied and in the same period, intravenous chemotherapy was performed using cisplatin (7 mg over 2 h) and 5-fluorouracil (5-FU; 350 mg over 24 h). Surgical treatment was performed in 20 patients in the CRT group except for two patients with bone metastasis after CRT. According to histological effects of primary tumors, the number of patient with Grades 1, 2 and 3 was 11, 7 and 3, respectively. Frequency of lymphatic and venous invasion was significantly lower in the CRT group than in the Surgery group. The 5-year survival rate was 57% in the CRT group and 41% in the Surgery group (P = 0.58). According to the histological effect in the CRT group, 5-year survival was 30% for Grade 1, 83% for Grade 2 and 100% for Grade 3 (P = 0.0069). This randomized trial did not demonstrate a statistically significant survival difference between the CRT group and the Surgery group.
引用
收藏
页码:468 / 472
页数:5
相关论文
共 36 条
  • [21] Natsugoe S, 1998, CANCER, V83, P858, DOI 10.1002/(SICI)1097-0142(19980901)83:5<858::AID-CNCR9>3.0.CO
  • [22] 2-E
  • [23] Number of lymph node metastases determined by presurgical ultrasound and endoscopic ultrasound is related to prognosis in patients with esophageal carcinoma
    Natsugoe, S
    Yoshinaka, H
    Shimada, M
    Sakamoto, F
    Morinaga, T
    Nakano, S
    Kusano, C
    Baba, M
    Takao, S
    Aikou, T
    [J]. ANNALS OF SURGERY, 2001, 234 (05) : 613 - 618
  • [24] Extranodal connective tissue invasion and the expression of desmosomal glycoprotein 1 in squamous cell carcinoma of the oesophagus
    Natsugoe, S
    Mueller, J
    Kijima, F
    Aridome, K
    Shimada, M
    Shirao, K
    Kusano, C
    Baba, M
    Yoshinaka, H
    Fukumoto, T
    Aikou, T
    [J]. BRITISH JOURNAL OF CANCER, 1997, 75 (06) : 892 - 897
  • [25] The predictive value of p53, p53R2, and p21 for the effect of chemoradiation therapy on oesophageal squamous cell carcinoma
    Okumura, H
    Natsugoe, S
    Matsumoto, M
    Mataki, Y
    Takatori, H
    Ishigami, S
    Takao, S
    Aikou, T
    [J]. BRITISH JOURNAL OF CANCER, 2005, 92 (02) : 284 - 289
  • [26] Osaka Y, 2004, ONCOL REP, V12, P1121
  • [27] Preoperative chemoradiotherapy prior to esophagectomy in elderly patients is not associated with increased morbidity
    Rice, DC
    Correa, AM
    Vaporciyan, AA
    Sodhi, N
    Smythe, WR
    Swisher, SG
    Walsh, GL
    Putnam, JB
    Komaki, R
    Ajani, JA
    Roth, JA
    [J]. ANNALS OF THORACIC SURGERY, 2005, 79 (02) : 391 - 397
  • [28] COX-2 inhibitors as radiation sensitizers for upper GI tract cancers: Esophagus, stomach, and pancreas
    Rich, TA
    Shepard, R
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2003, 26 (04): : S110 - S113
  • [29] Does neoadjuvant chemoradiation downstage esophageal carcinoma?
    Slater, MS
    Holland, J
    Faigel, DO
    Sheppard, BC
    Deveney, CW
    [J]. AMERICAN JOURNAL OF SURGERY, 2001, 181 (05) : 440 - 444
  • [30] Sobin L.H., 2009, UICC: TNM classification of malignant tumors, V7th